Panacea Venture is a life sciences venture capital firm with a global vision, focusing on investing in and incubating early-stage companies with disruptive technologies and discoveries that address unmet medical needs. Their strategy involves a "borderless execution model" and an "asset-centric" approach, investing across all life science subsectors with a therapeutic focus, and employing a "barbell strategy" that includes early-stage, expansion, and public company investments.
Portfolio
2
Fund Size
$276M
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Kainova Therapeutics | Series B | $32M | Feb 2026 |
| Actym Therapeutics | Series A | $59.5M | Oct 2023 |
Top Co-Investors
Illumina Ventures1 shared
Schroders Capital1 shared
Last updated: 3 March 2026